UCK2 and lung carcinoma: Similarly, the Kaplan-Meier survival analysis showed that pyrimidine metabolic rate–limiting enzymes DTYMK, NT5C3, RRM1, RRM2, TK1, TYMS, and UCK2 were all associated with adverse prognosis in the lung cancer (Fig. 6a).